Stocks · US
RMD
XNYS
ResMed Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E20.58x
P/B4.76x
P/S5.54x
EPS$10.83
ROE23.13%
ROA16.99%
Dividend yield1.12%
EV/EBITDA14.47x
Debt/Equity0.10
Free cash flow$1.6B
Returns and 52-week range
1W-0.96%
1M-3.35%
3M+7.21%
6M-2.37%
1Y-20.78%
YTD-9.85%
52W high$284.87
52W low$180.26
From 52W high-22.53%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 센틴 | $31.8B | — | 1.41 | -3.62% |
| Alcon Inc. Ordinary Shares | $31.1B | 70.68 | 1.59 | -10.37% |
| DexCom, Inc. | $32.8B | 32.80 | 12.51 | -5.13% |
| Mettler-Toledo International | $30.9B | 34.11 | 2,408.87 | +13.96% |
| Biogen Inc. Common Stock | $33.0B | 39.58 | 1.75 | +0.93% |
| ZOETIS INC. | $29.5B | 11.28 | 9.37 | -5.91% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.